Stay updated on Binimetinib Combo in RAS+ MSS mCRC Clinical Trial

Sign up to get notified when there's something new on the Binimetinib Combo in RAS+ MSS mCRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Binimetinib Combo in RAS+ MSS mCRC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site software version updated from v3.4.2 to v3.4.3. No study content or data are affected.
    Difference
    0.0%
    Check dated 2026-03-11T17:45:38.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.4.2' has been added, and the notice about government funding lapse along with the earlier 'Revision: v3.4.1' entry were removed.
    Difference
    0.3%
    Check dated 2026-02-11T02:16:08.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a banner noting government funding issues and that the NIH Clinical Center is open, with a link to status information. The page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T00:39:27.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary added and metadata updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' entries were removed.
    Difference
    0.1%
    Check dated 2026-01-27T23:56:34.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    - Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T01:11:31.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Expanded the Locations section with new study sites across the United States and internationally (California, Delaware, District of Columbia, Florida, Indiana, Missouri, Pennsylvania, Tennessee, Texas, North Holland, London - City of, Oxfordshire, Sutton) and updated the page to Revision: v3.3.3. The older revision entries (v3.3.2) were removed and the HHS Vulnerability Disclosure reference was deleted.
    Difference
    1.0%
    Check dated 2025-12-23T09:17:08.000Z thumbnail image

Stay in the know with updates to Binimetinib Combo in RAS+ MSS mCRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Binimetinib Combo in RAS+ MSS mCRC Clinical Trial page.